September 10, 2024
FDA Grants 510(k) Clearance to Sonic Incytes’ Velacur® Determined Fat Fraction (VDFF), a breakthrough for patients with MASLD and MASH
May 4, 2023
Sonic Incytes Receives FDA 510(k) Clearance of AI Powered Features for Velacur™ Liver Ultrasound
No current content.